Plain-English translation of NCT04068597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new drug called to see if it can help people with advanced blood cancers, including leukemia, lymphoma, and myeloma. Researchers want to find the right dose and understand how well this medication works, both when taken alone and when combined with other cancer treatments that are already in use.
People with advanced blood cancers often run out of treatment options, especially if their cancer stops responding to standard therapies. This trial exists to see whether this new medication could offer hope to patients whose cancers have become resistant to current treatments.
You likely qualify if…
You likely don't qualify if…
Participants will take the medication by mouth, starting at a carefully tested dose that may be adjusted based on how their body responds and any side effects. Depending on which group you join, you may receive the medication alone or in combination with one or more other approved cancer drugs. You will have regular visits with the research team to have blood tests, physical exams, and imaging scans to monitor how you're doing and how well the treatment is working.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States